Sex-Specific Medical Research Why Women’s Health Can’t Wait
Brigham and Women’s Hospital: 2/26/14 A Report of the Mary Horrigan Connors Center for Women’s Health & Gender Biology at Brigham and Women’s Hospital Twenty years ago, a bipartisan group of legislators worked with patients, providers, policy makers, and advocates to create and pass the 1993 National Institutes of Health Revitalization Act, a law mandating […]
A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials
Clinical Pharmacology & Therapeutics: 12/4/14 We propose an “efficacy-to-effectiveness” (E2E) clinical trial design, in which an effectiveness trial would commence seamlessly upon completion of the efficacy trial.Efficacy trials use inclusion/exclusion criteria to produce relatively homogeneous samples of participants with the target condition, conducted in settings that foster adherence to rigorous clinical protocols. Effectiveness trials use inclusion/exclusion criteria that generate […]
Pfizer supports development of the Clinical Trial Engagement Network
“Pfizer is working with the National Minority Quality Forum to push healthcare innovations to improve minority participations in clinical trials and to help innovators plan from the outset for more diverse trials. Together we’re proud to tell you about the National Clinical Trial Network, a new portal that gives patients, doctors, and researchers the tools […]
Who do I contact to join the Clinical Trial Engagement Network
For more information about becoming a Clinical Trial Engagement Network member, please contact Gary Puckrein (gpuckrein@nmqf.org) by email or by phone at 202.223.7560
